寧波華翔(002048.SZ):華翔投資擬協議轉讓5.99%的股份予周曉峯本人
格隆匯5月9日丨寧波華翔(002048.SZ)公佈,公司收到公司實際控制人——周曉峯的通知,其本人與其控制的寧波華翔股權投資有限公司(“華翔投資”)於2022年5月9日簽署了《股份轉讓協議》,華翔投資將其持有的寧波華翔48,736,437股流通股股份(佔公司股本總額的5.99%)全部協議轉讓給周曉峯本人。
由於華翔投資屬於周曉峯控制,此次權益變動後,公司實際控制人及其一致行動人持有的股份數量保持不變。此次轉讓尚須向深圳證券交易所辦理協議轉讓審核申請以及向中國證券登記結算有限責任公司深圳分公司辦理股份轉讓過户登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.